Olathe biotech startup TVAX clears FDA hurdles for treatments to combat deadly cancers
In partnership with a California company, TVAX Biomedical Inc. developed an immunotherapy treatment for pancreatic cancer.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Ellen Cagle Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Immunotherapy | Pancreas | Pancreatic Cancer | Partnerships